Table 4.
Prevalence of diabetic retinopathy, maculopathy, and sight-threatening DR among persons with diabetes assessed (Scottish classification) (N=5986)
| Total | N (%) | 95% CI |
|---|---|---|
| Retinopathy | ||
| No visible retinopathy (R0) | 4976 (83.1) | (82.1-84.1) |
| Mild (R1) | 705 (11.8) | (10.8-12.8) |
| Observable background (R2) | 155 (2.6) | (2.2-3.0) |
| Referable (R3) | 113 (1.9) | (1.6-2.3) |
| Proliferative (R4) | 37 (0.6) | (0.4-0.8) |
| Any retinopathy | 1010 (16.9) | (15.9-17.9) |
| Maculopathy | ||
| No maculopathy (M0) | 5569 (93.0) | (92.3-93.8) |
| Observable (M1) | 215 (3.6) | (3.1-4.2) |
| Referable (M2) | 202 (3.4) | (2.9-3.9) |
| Any Maculopathy | 417 (7.0) | (6.2-7.8) |
| Laser Scars | ||
| No Laser Scars | 5957 (99.5) | (99.3-99.7) |
| Pan retinal laser | 23 (0.4) | (0.3-0.6) |
| Macular laser | 1 (0.0) | (0.0-0.1) |
| Pan retinal and macular laser | 5 (0.1) | (0.0-0.3) |
| Any Retinopathy and/or Maculopathy | 1010 (16.9) | (15.9-17.9) |
| Sight Threatening DR (R4 or M2) | 214 (3.6) | (3.1-4.1) |